Fibrinogen Concentrate (Human) (FCH) + Placebo

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Surgical Blood Loss

Conditions

Surgical Blood Loss, Postoperative Blood Loss

Trial Timeline

Jan 1, 2012 → Sep 1, 2014

NCT ID

NCT01475669

About Fibrinogen Concentrate (Human) (FCH) + Placebo

Fibrinogen Concentrate (Human) (FCH) + Placebo is a phase 3 stage product being developed by CSL for Surgical Blood Loss. The current trial status is completed. This product is registered under clinical trial identifier NCT01475669. Target conditions include Surgical Blood Loss, Postoperative Blood Loss.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01475669	Phase 3	Completed	Jan 1, 2012	Sep 1, 2014	Surgical Blood Loss

Competing Products

20 competing products in Surgical Blood Loss

See all competitors

Product	Company	Stage	Hype Score
Celecoxib	Astellas Pharma	Pre-clinical	23
Nivolumab + Everolimus	Ono Pharmaceutical	Phase 3	77
Epoetin alfa + Standard of Care	Johnson & Johnson	Approved	85
HR021618 + HR021618 + Placebo	Jiangsu Hengrui Medicine	Phase 2	52
SHR0410 Injection + Placebo for SHR0410 Injection	Jiangsu Hengrui Medicine	Phase 2	52
Ertapenem	Merck	Approved	85
Sugammadex + Rocuronium	Merck	Approved	85
Deep neuromuscular block	Merck	Approved	85
Rocuronium	Merck	Approved	85
Ertapenem	Merck	Phase 2/3	65
Sugammadex + Neostigmine + Glycopyrrolate	Merck	Phase 3	77
Ecallantide + Placebo	Merck	Phase 2	52
Amicidin-β topical solution - 15 mL + Amicidin-β topical solution - 50 mL + Standard of Care (SOC)	Novo Nordisk	Phase 1	32
Insulin infusion with a goal	Novo Nordisk	Phase 3	76
parecoxib/valdecoxib	Pfizer	Approved	84
Tranexamic acid + Standard of Care	Pfizer	Approved	84
Ibuprofen 250 mg / Acetaminophen 500 mg + Ibuprofen 250 mg + Acetaminophen 650 mg + Placebo	Pfizer	Phase 3	76
valdecoxib + valdecoxib/placebo + placebo	Pfizer	Phase 3	76
PF-04531083 + PF-04531083 + Ibuprofen	Pfizer	Phase 2	51
Haemate HS	CSL	Phase 2	51

Other Products from CSL

IgPro10Approved

four factor prothrombin complex concentrateApproved

Prothrombin complex concentrate (Human) + Fresh frozen plasma (FFP)Approved

IgPro10Approved

Blood coagulation Factor VIII and vWF, humanApproved